Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

NCT00245622

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • North Central Neurology Associates, PC Cullman, Alabama, United States
  • Xenoscience - 21st Century Neurology Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • Alta Bates Summit Medical Center - East Bay Physicians Medical Group Berkeley, California, United States
View all 33 locations
View Trial Details
Completed

A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis

NCT00097188

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Phoenix Neurological Associates Phoenix, Arizona, United States
  • Loma Linda University Loma Linda, California, United States
  • Sutter Gould Medical Foundation Modesto, California, United States
  • University Of California At Davis Sacramento, California, United States
View all 31 locations
View Trial Details
Completed

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

NCT01591551

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • South Shore Neurologic Associates Patchogue, New York, United States
  • Cornerstone Neurology High Point, North Carolina, United States
  • Providence Brain Institute Portland, Oregon, United States
View Trial Details

Related conditions